NCDEU is a scientific meeting that focuses on the latest developments in psychopharmacologic clinical research and related methodology. The meeting brings together over 1200 academic and industry investigators, research pharmacists, and clinicians, including competitively selected New Investigator awardees. NCDEU is sponsored by the American Society of Clinical Psychopharmacology. NIMH, along with the National Institute on Drug AbuseExternal Link: Please review our disclaimer. and the Food and Drug AdministrationExternal Link: Please review our disclaimer., is a federal partner in presenting in this year’s NCDEU program.
June 13, 2011 – June 16, 2011
Boca Raton, Florida
This year’s program will focus on the latest developments in psychopharmacologic clinical research and related methodology. The theme is Anticipating the Future of Drug Development: New Targets, Integrative Biomarkers, and Beyond.
For information on the upcoming meeting, including topics of special interest, submission deadlines, and how to apply for the New Investigator Program, visit the NCDEU website (http://www.ncdeumeeting.org).
Learn More About NCDEU 2011
For more information and to register for the meeting, go to
web site: www.ncdeumeeting.org
Steering Committee Co-Chairs
- William Z. Potter, M.D., Ph.D.
- Nina R. Schooler, Ph.D.
- David J. Kupfer, M.D.
- Carlos A. Zarate, M.D.
New Investigator Award Program Co-Chairs
- Lauren D. Hill, Ph.D.
- Mark H. Rapaport, M.D.